Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells

Giulia Taraboletti, Patrizia Borsotti, R. G S Chirivi, Veronica Vergani, Anna Falanga, Tiziano Barbui, Raffaella Giavazzi, Alessandro Rambaldi

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

All trans-retinoic acid (ATRA) induces complete remission in acute-promyelocytic-leukemia (APL) patients. This study investigated the adhesive properties of APL cells for the endothelium and the extracellular matrix, their motility and the effect of ATRA on these functions. Blasts from 7 APL patients adhered to resting and IL-1-activated endothelium, to the same degree as normal PMN. Adhesion was partially mediated by ICAM-1 and, for IL-1-activated endothelium, by VCAM-1 and E-selectin. These cells showed less adhesiveness for the matrix than PMN, although they maintained the same substrate preference: they adhered to fibronectin and thrombospondin, but not to laminin and type-IV collagen. Exposure to ATRA in vitro (1 μM for 48 to 96 hr) increased the adhesiveness of APL cells; this effect was particularly evident in the case of sub-endothelial matrix and fibronectin. A similar increment in adhesiveness was observed when comparing cells from 2 patients before and after treatment with ATRA. APL cells migrated in response to fMLP and motility was increased by ATRA. In conclusion, APL cells were less adhesive to the matrix than PMN, but treatment with ATRA considerably enhanced their adhesive properties. This could be important in determining the efflux of leukemic cells from the bone marrow and their tissue infiltration during ATRA therapy.

Original languageEnglish
Pages (from-to)72-77
Number of pages6
JournalInternational Journal of Cancer
Volume70
Issue number1
DOIs
Publication statusPublished - 1997

Fingerprint

Acute Promyelocytic Leukemia
Tretinoin
Adhesives
Adhesiveness
Endothelium
Interleukin-1
Fibronectins
Thrombospondins
E-Selectin
Collagen Type IV
Vascular Cell Adhesion Molecule-1
Laminin
Intercellular Adhesion Molecule-1
Bone Marrow Cells
Extracellular Matrix
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells. / Taraboletti, Giulia; Borsotti, Patrizia; Chirivi, R. G S; Vergani, Veronica; Falanga, Anna; Barbui, Tiziano; Giavazzi, Raffaella; Rambaldi, Alessandro.

In: International Journal of Cancer, Vol. 70, No. 1, 1997, p. 72-77.

Research output: Contribution to journalArticle

Taraboletti, Giulia ; Borsotti, Patrizia ; Chirivi, R. G S ; Vergani, Veronica ; Falanga, Anna ; Barbui, Tiziano ; Giavazzi, Raffaella ; Rambaldi, Alessandro. / Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells. In: International Journal of Cancer. 1997 ; Vol. 70, No. 1. pp. 72-77.
@article{28017c691ebc486fab82da3218ffb56e,
title = "Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells",
abstract = "All trans-retinoic acid (ATRA) induces complete remission in acute-promyelocytic-leukemia (APL) patients. This study investigated the adhesive properties of APL cells for the endothelium and the extracellular matrix, their motility and the effect of ATRA on these functions. Blasts from 7 APL patients adhered to resting and IL-1-activated endothelium, to the same degree as normal PMN. Adhesion was partially mediated by ICAM-1 and, for IL-1-activated endothelium, by VCAM-1 and E-selectin. These cells showed less adhesiveness for the matrix than PMN, although they maintained the same substrate preference: they adhered to fibronectin and thrombospondin, but not to laminin and type-IV collagen. Exposure to ATRA in vitro (1 μM for 48 to 96 hr) increased the adhesiveness of APL cells; this effect was particularly evident in the case of sub-endothelial matrix and fibronectin. A similar increment in adhesiveness was observed when comparing cells from 2 patients before and after treatment with ATRA. APL cells migrated in response to fMLP and motility was increased by ATRA. In conclusion, APL cells were less adhesive to the matrix than PMN, but treatment with ATRA considerably enhanced their adhesive properties. This could be important in determining the efflux of leukemic cells from the bone marrow and their tissue infiltration during ATRA therapy.",
author = "Giulia Taraboletti and Patrizia Borsotti and Chirivi, {R. G S} and Veronica Vergani and Anna Falanga and Tiziano Barbui and Raffaella Giavazzi and Alessandro Rambaldi",
year = "1997",
doi = "10.1002/(SICI)1097-0215(19970106)70:1<72::AID-IJC11>3.0.CO;2-F",
language = "English",
volume = "70",
pages = "72--77",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells

AU - Taraboletti, Giulia

AU - Borsotti, Patrizia

AU - Chirivi, R. G S

AU - Vergani, Veronica

AU - Falanga, Anna

AU - Barbui, Tiziano

AU - Giavazzi, Raffaella

AU - Rambaldi, Alessandro

PY - 1997

Y1 - 1997

N2 - All trans-retinoic acid (ATRA) induces complete remission in acute-promyelocytic-leukemia (APL) patients. This study investigated the adhesive properties of APL cells for the endothelium and the extracellular matrix, their motility and the effect of ATRA on these functions. Blasts from 7 APL patients adhered to resting and IL-1-activated endothelium, to the same degree as normal PMN. Adhesion was partially mediated by ICAM-1 and, for IL-1-activated endothelium, by VCAM-1 and E-selectin. These cells showed less adhesiveness for the matrix than PMN, although they maintained the same substrate preference: they adhered to fibronectin and thrombospondin, but not to laminin and type-IV collagen. Exposure to ATRA in vitro (1 μM for 48 to 96 hr) increased the adhesiveness of APL cells; this effect was particularly evident in the case of sub-endothelial matrix and fibronectin. A similar increment in adhesiveness was observed when comparing cells from 2 patients before and after treatment with ATRA. APL cells migrated in response to fMLP and motility was increased by ATRA. In conclusion, APL cells were less adhesive to the matrix than PMN, but treatment with ATRA considerably enhanced their adhesive properties. This could be important in determining the efflux of leukemic cells from the bone marrow and their tissue infiltration during ATRA therapy.

AB - All trans-retinoic acid (ATRA) induces complete remission in acute-promyelocytic-leukemia (APL) patients. This study investigated the adhesive properties of APL cells for the endothelium and the extracellular matrix, their motility and the effect of ATRA on these functions. Blasts from 7 APL patients adhered to resting and IL-1-activated endothelium, to the same degree as normal PMN. Adhesion was partially mediated by ICAM-1 and, for IL-1-activated endothelium, by VCAM-1 and E-selectin. These cells showed less adhesiveness for the matrix than PMN, although they maintained the same substrate preference: they adhered to fibronectin and thrombospondin, but not to laminin and type-IV collagen. Exposure to ATRA in vitro (1 μM for 48 to 96 hr) increased the adhesiveness of APL cells; this effect was particularly evident in the case of sub-endothelial matrix and fibronectin. A similar increment in adhesiveness was observed when comparing cells from 2 patients before and after treatment with ATRA. APL cells migrated in response to fMLP and motility was increased by ATRA. In conclusion, APL cells were less adhesive to the matrix than PMN, but treatment with ATRA considerably enhanced their adhesive properties. This could be important in determining the efflux of leukemic cells from the bone marrow and their tissue infiltration during ATRA therapy.

UR - http://www.scopus.com/inward/record.url?scp=0031038265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031038265&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19970106)70:1<72::AID-IJC11>3.0.CO;2-F

DO - 10.1002/(SICI)1097-0215(19970106)70:1<72::AID-IJC11>3.0.CO;2-F

M3 - Article

C2 - 8985093

AN - SCOPUS:0031038265

VL - 70

SP - 72

EP - 77

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -